Intake of 1-deoxynojirimycin suppresses lipid accumulation through activation of the β-oxidation system in rat liver

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 22, 2009, Pages 11024-11029

  Tsuduki, Tsuyoshi ^a   Nakamura, Yumiko ^b   Honma, Taro ^a   Nakagawa, Kiyotaka ^b   Kimura, Toshiyuki ^c   Ikeda, Ikuo ^a   Miyazawa, Teruo ^b  

^a Laboratory of Food and Biomolecular Science   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NATIONAL AGRICULTURAL RESEARCH CENTER FOR TOHOKU REGION   (Japan)

Author keywords

oxidation; Adiponectin; AMPK; Deoxynojirimycin; Mulberry; Rat

Indexed keywords

1 DEOXYNOJIRIMYCIN; ADIPONECTIN; FATTY ACID; MESSENGER RNA; PLANT EXTRACT;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; FRUIT; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; LIVER; MALE; METABOLISM; MULBERRY; OXIDATION REDUCTION REACTION; RAT; SPRAGUE DAWLEY RAT;

1-DEOXYNOJIRIMYCIN; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; FATTY ACIDS; FRUIT; GENE EXPRESSION; LIPID METABOLISM; LIVER; MALE; MORUS; OXIDATION-REDUCTION; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

MORUS (PLANT); RATTUS;

EID: 72449194752     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf903132r     Document Type: Article

References (30)

1. Bray, G. A.; Popkin, B. M. Dietary fat intake does affect obesity!. Am. J. Clin. Nutr. 1998, 68, 1157-1173.
2. (2) Nakamura, T.; Tokunaga, K.; Shimomura, I.; Nishida, M.; Yoshida, S.; Kotani, K.; Islam, A. H.; Keno, Y.; Kobatake, T.; Nagai, Y. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men Atherosclerosis 1994, 107, 239-246. (Pubitemid 24206863)
3. Sharadi, Y.; Eldad, A. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity, Am. J. Med. 2000, 109,171.
4. Bouloumie, A.; Drexler, H. C.; Lafontan, M.; Busse, R. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 1998, 83, 1059-1066.
5. Hu, E.; Liang, P.; Spiegelman, B. M. AdipoQ is a novel adipocytespecific gene dysregulated in obesity. J. Biol. Chem. 1996, 271, 10679-10703.
6. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K,; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M. L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
7. Yagi, M.; Kouno, T.; Aoyagi, Y.; Murai, H. The structure of moraoline, a piperidine alkaloid from Morus species. Nippon Nougei Kagaku Kaishi 1916, 50, 571-572.
8. (8) Miyahara, C.; Miyazawa, M.; Satoh, S.; Sakai, A.; Mizusaki, S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats, J. Nutr. Sci. Vitaminol 2004, 50,161-164. (Pubitemid 39045117)
9. (9) Singab, A. N. B.; El-beshbishy, H. A.; Yonekawa, M.; Nomurac, T.; Fukai, T. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocininduced diabetic rats. J. Ethnopharmacol 2005, 100, 333-338. (Pubitemid 41206631)
10. Asano, N.; Yamashita, T.; Yasuda, K.; Ikeda, K.; Kizu, H.; Kameda, Y.; Kato, A.; Nash, R. J.; Lee, H. S.; Ryu, K. S. Polyhydroxylated alkaloids isolated from, mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem. 2001, 49, 4208-4213.
11. (11) Kimura, T.; Nakagawa, K.; Kubota, H.; Kojima, Y.; Goto, Y.; Yamagishi, K.; Oita, S.; Oikawa, S.; Miyazawa, T. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in human. J. Agric. Food Chem. 2007, 55, 5869-5874. (Pubitemid 47092969)
12. (12) Nakagawa, K.; Kubota, H.; Kimura, T.; Yamashita, S.; Tsuzuki, T.; Oikawa, S.; Miyazawa, T. Occurrence of orally administered mulberry 1-deoxynojirimycin in rat plasma. J. Agric. Food Chem. 2007, 55, 8928-8933. (Pubitemid 350105538)
13. Tsuzuki, T.; Ikeda, I. Slow absorption of conjugated linoleic acid in rat intestines, and similar absorption rates of 9c, 11t-conjugated linoleic acid and 10t, 12c-conjugated linoleic acid. Biosci,. Biotechnol., Biochem. 2007, 71, 2034-2040.
14. (14) Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagawa, K.; Miyazawa, T. Anti-angiogenic effects of conjugated docosahexaenoic acid in vitro and in vivo, Biosci., Biotechnol., Biochem. 2007, 71, 1902-1910. (Pubitemid 350113151)
15. Bartlett, G. R. Colorimetric assay methods for free and phosphorylated glyceric acids. J. Biol. Chem. 1951, 226, 497-509.
16. (16) Tsuzuki, T.; Tokuyama, Y.; Igarashi, M.; Miyazawa, T. Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 2004, 25, 1417-1425. (Pubitemid 39162707)
17. Ide, T.; Kobayashi, H.; Ashakumary, L.; Rouyer, I. A.; Takahashi, Y.; Aoyama, T.; Hashimoto, T.; Mizugaki, M. Comparative effects of perilla and fish oils on the activity and gene expression of fatty acid oxidation enzymes in rat liver. Biochim. Biophys. Acta 2000, 1485, 23-35.
18. (18) Tsuzuki, T.; Kawakami, Y.; Nakagawa, K.; Miyazawa, T. Conjugated docosahexaenoic acid inhibits lipid accumulation in rats. J. Nutr. Biochem. 2006, 17, 518-524. (Pubitemid 44066763)
19. (19) Tsuzuki, T.; Kambe, T.; Shibata, A.; Kawakami, Y.; Nakagawa, K.; Miyazawa, T. Conjugated EPA activates mutant p53 via lipid peroxidation and induces p53-dependent apoptosis in DLD-1 colorectal adenocarcinoma human cells, Biochim. Biophys. Acta 2007, 1771, 20-30. (Pubitemid 46073886)
20. (20) Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagawa, K.; Miyazawa, T. Conjugated eicosapentaenoic acid inhibits the VEGF-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cell, J. Nutr. 2007, 137, 641-646. (Pubitemid 46397496)
21. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; Kuriyama, H.; Nishida, M.; Yamashita, S.; Okubo, K.; Matsubara, K.; Muraguchi, M.; Ohmoto, Y.; Funahashi, T.; Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257, 79-83.
22. (22) Weyer, C.; Funahashi, T.; Tanaka, S.; Hotta, K.; Matsuzawa, Y.; Pratley, R. E.; Tataranni, P. A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86, 1930-1935. (Pubitemid 32472900)
23. Niwa, T.; Inoue, S.; Tsuruoka, T.; Koaze, Y.; Niida, T. Nojirimycin as a potent inhibitor of glucosidase. Agric. Biol. Chem. 1970, 34, 966-968.
24. Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Sugarmimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron: Asymmetry 2000, 11, 1645-1680.
25. Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Polyhydroxylated alkaloids: natural occurrence and therapeutic applications. Phytochemistry 2001, 56, 265-295.
26. (26) Segal, P.; Feig, P. U.; Schernthaner, G.; Ratzmann, K. P.; Rybka, J.; Petzinna, D.; Berlin, C. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with type 2 diabetes inadequately controlled by diet alone. Diabetes Care 1997, 20, 687-691. (Pubitemid 27202513)
27. (27) Cox, T.; Lachmann, R.; Hollak, C.; Aerts, J.; van Weely, S.; Hrebicek, M.; Platt, F.; Butters, T.; Dwek, R.; Moyses, C.; Gow, I.; Elstein, D.; Zimran, A. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 2000, 355, 1481-1485. (Pubitemid 30237353)
28. Junge, B.; Matzke, M.; Stltefuss, J. Chemistry and structure - activity relationships of glucosidase inhibitors. In Handbook of Experimental Pharmacology; Kuhlmann, J., Puls, W., Eds.; Springer-Verlag: New York, 1996; Vol.199, pp 411-482.
29. Yamauchi, T.; Kamon, J.; Minokoshi, Y.; Ito, Y.; Waki, H.; Uchida, S.; Yamashita, S.; Noda, M.; Kita, S.; Ueki, K.; Eto, K.; Akanuma, Y.; Froguel, P.; Foufelle, F.; Ferre, P.; Carling, D.; Kimura, S.; Nagai, R.; Kahn, B. B.; Kadowaki, T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase, Nat. Med. 2002, 8, 1288-1295.
30. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.; Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.; Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno, N. H.; Shibata, Y.; Terauchi, Y.; Froguel, P.; Tobe, K.; Koyasu, S.; Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R.; Kadowaki, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423, 762-769.